Xilio Therapeutics, Inc. ($XLO)
Filing Information
| Accession Number | 0001193125-26-002517 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
714,569
Total Value
$4,521.70
P&L
+inf% (+$4,875,471.81)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 1, 2026 | Exercise/Conversion | 19,375 | โ | โ | 31,796 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 2, 2026 | Sale | 7,030 | $0.64 | $4,521.70 | 24,766 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Dec 31, 2025 | Grant/Award | 668,789 | $0.00 | $0.00 | 668,789 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jan 1, 2026 | Exercise/Conversion | 19,375 | $0.00 | $0.00 | 38,750 | Direct | โ | View Details |